Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Takeyama (Tokyo, Japan), T. Akaba (Tokyo, Japan), A. Kurokawa (Tokyo, Japan), K. Arimura (Tokyo, Japan), M. Kondo (Tokyo, Japan), E. Tagaya (Tokyo, Japan). Analysis of airway mucin concentration in patients with pulmonary eosinophilia. 4390

Member's Comments

No comment yet.

Related content which might interest you: Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Relationship between peripheral airway obstruction and airway inflammation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 509s Year: 2006 Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Effect of bronchial neutrophilia on airway remodeling in asthma Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 The lung microcirculation changes in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 407s Year: 2006 Bronchial hyperresponsiveness in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020 Year: 2020 Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020 Year: 2020 Stability of eosinophilic inflammation in COPD bronchial biopsies Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020 Year: 2020 Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001 Relationship between induced sputum eosinophilia and endothelial dysfunction in children with bronchial asthma Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Steroids and airway mucosal vascularity in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005 Reversibility of airway obstruction in sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003